In Figure 1 of the article by Drs. Ryan D. Gentzler and Jyoti D. Patel titled “Optimal First-Line and Maintenance Treatments for Advanced-Stage Nonsquamous Non-Small Cell Lung Cancer,” published in the June 2014 issue of JNCCN (2014;12:889-897), the first node in the “Yes” pathway for “Significant concerns about alopecia or neutropenia” should have read, “Platinum/pemetrexed + bevacizumab” (page 894).
The editorial office apologizes for this error. A corrected copy of the editorial is available online at JNCCN.org.
